The effect of ruboxistaurin mesylate (LY333531) on small fiber function as measured by microvascular skin blood flow, C-fiber quantitations in skin and quantitative sensory testing of cold and heat

Trial Profile

The effect of ruboxistaurin mesylate (LY333531) on small fiber function as measured by microvascular skin blood flow, C-fiber quantitations in skin and quantitative sensory testing of cold and heat

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2016

At a glance

  • Drugs Ruboxistaurin (Primary)
  • Indications Diabetic neuropathies
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 11 Aug 2006 Status change
    • 07 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top